Capone Mark Christopher 4
4 · MYRIAD GENETICS INC · Filed Sep 26, 2019
Insider Transaction Report
Form 4
Capone Mark Christopher
Chief Operating Officer, MGL
Transactions
- Award
Common Stock
2019-09-25+142,500→ 583,333 total - Disposition to Issuer
Common Stock
2019-09-25$29.93/sh−15,800$472,894→ 567,533 total - Disposition to Issuer
Common Stock
2019-09-25$29.93/sh−18,295$547,569→ 549,238 total
Footnotes (2)
- [F1]Consists of performance stock units granted pursuant to the Companys 2017 Employee, Director and Consultant Equity Incentive Plan. Performance stock units initially granted on September 19, 2018, subject to accomplishment of pre-determined financial performance requirements. On September 25, 2019, the Compensation Committee determined the final award amount based on the accomplishment of the applicable financial performance requirements. Each performance stock unit represents a contingent right to receive one share of the Company?s common stock,and vests 25% on September 25, 2019, 25% on September 25, 2020, 25% on September 25, 2021, and 25% on September 25, 2022.
- [F2]Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance stock units granted to the reporting person.